🇺🇸 FDA
Patent

US 10703698

Compounds which activate estrogen receptors and compositions and methods of using the same

granted A61PA61P25/00A61P35/00

Quick answer

US patent 10703698 (Compounds which activate estrogen receptors and compositions and methods of using the same) held by The Board of Regents of the University of Texas System expires Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jul 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61P, A61P25/00, A61P35/00